The crystal structure of Ac-AChBP in complex with α-conotoxin LvIA reveals the mechanism of its selectivity towards different nAChR subtypes

Abstract

The α3* nAChRs, which are considered to be promising drug targets for problems such as pain, addiction, cardiovascular function, cognitive disorders etc., are found throughout the central and peripheral nervous system. The α-conotoxin (α-CTx) LvIA has been identified as the most selective inhibitor of α3β2 nAChRs known to date, and it can distinguish the α3β2 nAChR subtype from the α6/α3β2β3 and α3β4 nAChR subtypes. However, the mechanism of its selectivity towards α3β2, α6/α3β2β3, and α3β4 nAChRs remains elusive. Here we report the co-crystal structure of LvIA in complex with Aplysia californica acetylcholine binding protein (Ac-AChBP) at a resolution of 3.4 Å. Based on the structure of this complex, together with homology modeling based on other nAChR subtypes and binding affinity assays, we conclude that Asp-11 of LvIA plays an important role in the selectivity of LvIA towards α3β2 and α3/α6β2β3 nAChRs by making a salt bridge with Lys-155 of the rat α3 subunit. Asn-9 lies within a hydrophobic pocket that is formed by Met-36, Thr-59, and Phe-119 of the rat β2 subunit in the α3β2 nAChR model, revealing the reason for its more potent selectivity towards the α3β2 nAChR subtype. These results provide molecular insights that can be used to design ligands that selectively target α3β2 nAChRs, with significant implications for the design of new therapeutic α-CTxs.

Keywords

base editor / high-fidelity / mouse embryos / proximal-site deamination / whole-genome sequencing

References

[1] AdamsPD (2002) PHENIX: building new software for automated crystallographic structure determination.Acta Crystallogr Sect D-Biol Crystallogr58:1948–1954

[2] AzamL, McIntoshJM (2009) Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.Acta Pharmacol Sin30(6):771–783

[3] BeroukhimR, UnwinN (1995) Three-dimensional location of the main immunogenic region of the acetylcholine receptor.Neuron15(2):323–331

[4] BourneY (2005) Crystal structure of a Cbtx nd antagonistbound s essential interactions between snake α-neurotoxins and nicotinic receptors.The EMBO Journal24(8):1512–1522

[5] BrejcK (2001) Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.Nature411(6835):269–276

[6] CecchiniM, ChangeuxJ-P (2015) The nicotinic acetylcholine receptor and its prokaryotic homologues: Structure, conformational transitions & allosteric modulation.Neuropharmacology96 (Part B):137–149

[7] CeliePHN (2004) Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures.Neuron41(6):907–914

[8] CeliePHN (2005) Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an [alpha]-conotoxin PnIA variant.Nat Struct Mol Biol12(7):582–588

[9] DavisIW (2004) MOLPROBITY: structure validation and allatom contact analysis for nucleic acids and their complexes.Nucleic Acids Res32(Web Server issue):W615–W619

[10] DavisIW (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.Nucleic Acids Res35 (Web Server issue):W375–W383

[11] DellisantiCD (2007) Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.Nat Neurosci10(8):953–962

[12] DineleyKT, PandyaAA, YakelJL (2015) Nicotinic ACh receptors as therapeutic targets in CNS disorders.Trends Pharmacol Sci36 (2):96–108

[13] DutertreS (2007) AChBP-targeted alpha-conotoxin correlates distinct binding orientations with nAChR subtype selectivity.EMBO J26(16):3858–3867

[14] EmsleyP, CowtanK (2004) Coot: model-building tools for molecular graphics.Acta Crystallogr Sect D-Biol Crystallogr60:2126–2132

[15] HansenSB(2005) Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.EMBO J24(20):3635–3646

[16] HendricksonL, GuildfordM, TapperA (2013) Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence.Front Psychiatry. doi:10.3389/fpsyt.2013.00029

[17] HoneAJ (2013) Positional scanning mutagenesis of alphaconotoxin PeIA identifies critical residues that confer potency and selectivity for alpha6/alpha3beta2beta3 and alpha3beta2 nicotinic acetylcholine receptors.J Biol Chem288(35):25428–25439

[18] HurstR, RollemaH, BertrandD (2013) Nicotinic acetylcholine receptors: from basic science to therapeutics.Pharmacol Ther137(1):22–54

[19] KarlinA (2002) Emerging structure of the nicotinic acetylcholine receptors.Nat Rev Neurosci3(2):102–114

[20] KouvatsosN (2016) Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly: Ligandbound alpha2 homopentamer.Proc Natl Acad Sci USA113 (34):9635–9640

[21] LaskowskiRA (1993) PROCHECK—a program to check the stereochemical quality of protein structures.J Appl Crystallogr26:283–291

[22] LavioletteSR, van der KooyD (2004) The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour.Nat Rev Neurosci5(1):55–65

[23] Le NovereN, CorringerPJ, ChangeuxJP (2002) The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences.J Neurobiol53(4):447–456

[24] LebbeEK (2014) Conotoxins targeting nicotinic acetylcholine receptors: an overview.Mar Drugs12(5):2970–3004

[25] LiS-X (2011) Ligand-binding domain of an [alpha]7-nicotinic receptor chimera and its complex with agonist.Nat Neurosci14 (10):1253–1259

[26] LinB (2016) From crystal structure of α-conotoxin GIC in complex with Ac-AChBP to molecular determinants of its high selectivity for α3β2 nAChR.Scientific Reports6:22349

[27] LuoS (2010) Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor.J Biol Chem285(16):12355–12366

[28] LuoS(2014) A novel alpha4/7-conotoxin LvIA from Conus lividus that selectively blocks alpha3beta2 vs. alpha6/alpha3beta2beta3 nicotinic acetylcholine receptors.FASEB J28(4):1842–1853

[29] McCoyAJ (2007) Phaser crystallographic software.J Appl Crystallogr40(Pt 4):658–674

[30] McDougalOM (2013) pKa determination of histidine residues in alpha-conotoxin MII peptides by 1H NMR and constant pH molecular dynamics simulation.JPhysChemB117(9):2653–2661

[31] MirR (2016) Conotoxins: structure, therapeutic potential and pharmacological applications.Curr Pharm Des22(5):582–589

[32] MiyazawaA (1999) Nicotinic acetylcholine receptor at 4.6 Å resolution: transverse tunnels in the channel1.J Mol Biol288 (4):765–786

[33] Morales-PerezCL, NovielloCM, HibbsRE (2016) X-ray structure of the human alpha4beta2 nicotinic receptor.Nature538 (7625):411–415

[34] NemeczA, TaylorP (2011) Creating an alpha7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses.J Biol Chem286(49):42555–42565

[35] OrtellsMO, LuntGG (1995) Evolutionary history of the ligand-gated ion-channel superfamily of receptors.Trends Neurosci18 (3):121–127

[36] OtwinowskiZ, MinorW (1997) Processing of X-ray diffraction data collected in oscillation mode.Macromol Crystallogr Pt A276:307–326

[37] PaoliniM, De BiasiM (2011) Mechanistic insights into nicotine withdrawal.Biochem Pharmacol82(8):996–1007

[38] RucktooaP, SmitAB, SixmaTK (2009) Insight in nAChR subtype selectivity from AChBP crystal structures.Biochem Pharmacol78 (7):777–787

[39] SalasR (2009) Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice.J Neurosci29(10):3014–3018

[40] SambasivaraoSV (2014) Cover picture: acetylcholine promotes binding of α-conotoxin MII at α3β2 nicotinic acetylcholine receptors (ChemBioChem 3/2014).ChemBioChem15 (3):413–424

[41] SmitAB (2001) A glia-derived acetylcholine-binding protein that modulates synaptic transmission.Nature411(6835):261–268

[42] TsetlinV, UtkinY, KasheverovI (2009) Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.Biochem Pharmacol78(7):720–731

[43] UlensC (2006) Structural determinants of selective alphaconotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.Proc Natl Acad Sci USA103(10):3615–3620

[44] UnwinN (1993) Nicotinic acetylcholine receptor an 9 Å resolution.J Mol Biol229(4):1101–1124

[45] UnwinN (1995) Acetylcholine receptor channel imaged in the open state.Nature373(6509):37–43

[46] UnwinN (2005) Refined structure of the nicotinic acetylcholine receptor at 4A resolution.J Mol Biol346(4):967–989

[47] WebbB, SaliA (2014) Comparative protein structure modeling using MODELLER.Curr Protoc Bioinform47:5.6.1–5.6.32

[48] ZhangsunD (2015) Key residues in the nicotinic acetylcholine receptor beta2 subunit contribute to alpha-conotoxin LvIA binding.J Biol Chem290(15):9855–9862

[49] ZoliM, PistilloF, GottiC (2015) Diversity of native nicotinic receptor subtypes in mammalian brain.Neuropharmacology96(Pt B):302–311

[50] ZouridakisM (2014) Crystal structures of free and antagonistbound states of human alpha9 nicotinic receptor extracellular domain.Nat Struct Mol Biol21(11):976–980

RIGHTS & PERMISSIONS

2017 The Author(s) 2017. This article is an open access publication